Project Grant R01DK147123
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Medical College of Wisconsin, Inc. a Project Grant of $432,625 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop animal models and resources for preclinical lower urinary tract research. The award, effective August 6, 2025, through July 31, 2027, supports the creation of a comprehensive dataset measuring urological...
- Federal Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a $765,701 Project Grant award dated September 9, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds basic biomedical research to map mechanosensory neural circuits controlling bladder sensation and urination through the completion date of May 31, 2030. The research will employ...
- Federal Project Grant Award Summary The University of Wisconsin–Madison received a $614,102 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded April 1, 2026, with a completion date of March 31, 2030. This award supports basic biomedical research aimed at improving understanding of parenteral nutrition-associated liver disease (PNALD) in pediatric...
- Federal Project Grant Award Summary Virginia Commonwealth University received a $177,350 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2030. The project develops objective analytical tools and predictive methodologies to advance sacral neuromodulation (SNM) treatment optimization for overactive bladder...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,429,924 Project Grant to Texas A&M Engineering Experiment Station on September 18, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This four-year project (completion date: September 17, 2029) supports the development of a novel magnetoelastic dynamic midurethral sling designed to treat stress urinary incontinence (SUI), a...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $512,595 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded April 15, 2026, with completion scheduled for February 28, 2030. The research project focuses on elucidating a novel neural circuit linking estrogen-responsive neurons in the hypothalamus to...
- Federal Project Grant Award Summary Beth Israel Deaconess Medical Center, Inc. (BIDMC) received a $739,141 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on April 22, 2026, with a completion date of March 31, 2031. The research investigates the role of adiponectin signaling in regulating bladder function and lower urinary tract symptoms (LUTS),...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $796,742 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 6, 2026, with completion targeted for December 31, 2029. The grant funds research to develop urinary peptidomics biomarkers for risk stratification in patients with spina...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $694,934 to the Regents of the University of Minnesota on May 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This project grant, scheduled for completion on March 31, 2031, funds basic biomedical research investigating the modulation of interoception by TRPV1-expressing renal afferent nerves. The research addresses...
- Federal Grant Award Summary Drexel University received a $149,190 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective July 14, 2026, with completion targeted for February 29, 2028. The research project, conducted in Philadelphia, Pennsylvania, investigates the mechanisms by which transcutaneous spinal cord stimulation (TSCS) reduces...
The Medical College of Wisconsin, Inc. received a $751,694 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 21, 2026, with a completion date of February 28, 2031. This award funds preclinical research to optimize tibial nerve stimulation (TNS) therapy for treating neurogenic bladder dysfunction in individuals with spinal cord injury (SCI). The research utilizes a novel wireless tibial nerve stimulator to investigate critical unanswered questions regarding TNS dosing parameters, intervention timing, and long-term therapeutic effectiveness in a rat model of SCI. The project deliverables include three primary research aims: (1) evaluating how varying TNS dosing intervals and durations influence functional bladder recovery following SCI; (2) assessing optimal timing for TNS intervention across different SCI recovery phases to maximize therapeutic efficacy; and (3) examining how chronic TNS dosing duration affects treatment outcomes. This research is designed to clarify TNS stimulation parameters and generate evidence necessary to inform future clinical trials and improve therapeutic outcomes for patients with neurogenic bladder disorders.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $751.7k | 4/27/26 |